Skip to content
Screener

Guardian Pharmacy Services GRDN EV / EBITDA

EV / EBITDA at other companies

CVS Health logo
CVS HealthCVS
15.2×+8.4×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
Omnicell logo
OmnicellOMCL
11.9×+1.6×
Cardinal Health logo
Cardinal HealthCAH
16.9×+4.4×
Cencora logo
CencoraCOR
15.6×-0.8×
Elevance Health logo
Elevance HealthELV
11.8×+0.4×

Other financials

Income statement

See full
Revenue$351.8M+2.2%
Gross profit$80.0M+17.5%
Operating income$20.6M+64.1%
Net income$21.9M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$89.8M+377%
Total debt$35.2M+4.6%
Total equity$257.6M+43.4%
Total assets$443.6M+24.5%

Cash flow

See full
Operating cash flow$30.0M+50.6%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.5B+88.6%
Enterprise value$2.44B+82.4%
P/E37.9×—
P/S1.7×+0.7×

Profitability

See full
Gross margin21.6%+2.0pp
Operating margin5.8%—
Net margin4.5%+2.8pp

Returns & leverage

See full
Return on equity30.1%—
Debt / equity0.1×-0.1×
Current ratio1.7×+0.5×

Where this comes from

Calculated from Guardian Pharmacy Services’s reported figures.

enterprise value/ebitda=23.9×

Based on the most recent quarter.

The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338074

FAQ

What is Guardian Pharmacy Services's EV / EBITDA?
Guardian Pharmacy Services (GRDN) reported EV / EBITDA of 23.9× in Q2 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Guardian Pharmacy Services's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude